DiaMedica Therapeutics Inc. (DMAC)
NASDAQ·Healthcare·Biotechnology
$9.65
+10.99%
Mkt Cap $468.61M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$8.33
Range $7.00 – $10.00
Implied Upside
-13.6%
Consensus $8.33 vs current $9.65
NASDAQ·Healthcare·Biotechnology
$9.65
+10.99%
Mkt Cap $468.61M
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$8.33
Range $7.00 – $10.00
-13.6%
Consensus $8.33 vs current $9.65